热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE anti-mouse CD206 (MMR) Antibody
产品名称：
PE anti-mouse CD206 (MMR) Antibody
产品类别：
抗体
产品编号：
141705
产品应用：
141705
[价格]
规格 价格 库存
25µg ￥ 129 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Recombinant mouse CD206 (MMR)
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
FC - Verified
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 ?g per million cells in 100 ?l volume.? It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.

Application References

(PubMed link indicates BioLegend citation)
  1. Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed
  2. Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed
  3. Yang X, et al. 2015. PNAS. 112:2900. PubMed
  4. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  5. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Cui J, et al. 2021. J Cell Mol Med. 25:5586. PubMed
  2. Zhang B, et al. 2022. Front Med (Lausanne). 8:796743. PubMed
  3. Zhang Z, et al. 2022. Front Pharmacol. 13:906625. PubMed
  4. Michela Miani et al. 2018. Cell metabolism. 28(4):557-572 . PubMed
  5. Feng Y, et al. 2018. J Am Soc Nephrol. 29:182. PubMed
  6. Seo JB, et al. 2019. Nat Metab. 1:86. PubMed
  7. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  8. Sun H, et al. 2019. Mol Hum Reprod. 25:05:00. PubMed
  9. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  10. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  11. Hu S, et al. 2018. Front Immunol. 9:01. PubMed
  12. Ying W et al. 2017. Cell. 171(2):372-384 . PubMed
  13. Sadek J, et al. 2021. EMBO Mol Med. 13:e13591. PubMed
  14. Li Q, et al. 2021. Front Immunol. 12:707784. PubMed
  15. Nomura M, et al. 2016. Nat Immunol. 17:216-217. PubMed
  16. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  17. Zheng W, et al. 2021. Wellcome Open Research. 6:52. PubMed
  18. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  19. Dong L, et al. 2021. Cancer Cell. . PubMed
  20. Clarke F,et al. 2017. PLoS One. 10.1371/journal.pone.0186625. PubMed
  21. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  22. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  23. De Vlaeminck Y, et al. 2020. Cancers (Basel). 12:. PubMed
  24. Li J, et al. 2021. Front Immunol. 12:649285. PubMed
  25. Krukowski K, et al. 2021. Sci Adv. 7:eabg6702. PubMed
  26. Pajarinen J, et al. 2021. J Biomed Mater Res A. 109:1512. PubMed
  27. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  28. Shao H, et al. 2012. J Biol Chem. 287:35860. PubMed
  29. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  30. Tanner L, et al. 2022. Front Pharmacol. 13:899469. PubMed
  31. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  32. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  33. Jia X, et al. 2021. Front Cell Dev Biol. 9:685522. PubMed
  34. He C, et al. 2021. Oncoimmunology. 1897295:10. PubMed
  35. Tang TT, et al. 2020. Sci Adv. 6:eaaz0748. PubMed
  36. Mul Fedele ML, et al. 2020. Front Cell Infect Microbiol. 10:100. PubMed
  37. El–Achkar GA, et al. 2019. PLoS One. 14:e0216405. PubMed
  38. McKee AM, et al. 2021. iScience. 24:103012. PubMed
  39. Zhang Y, et al. 2022. Nat Commun. 13:4553. PubMed
  40. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  41. Giri J, et al. 2020. Cell Rep. 30:1923. PubMed
  42. Dan H, et al. 2020. Mol Oncol. 14:795. PubMed
  43. Kim JS, et al. 2020. Int J Oncol. 56:1405. PubMed
  44. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  45. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  46. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  47. Martins L, et al. 2020. Stem Cell Res Ther. 0.786805556. PubMed
  48. Farini A, et al. 2020. Front Physiol. 0.738194444. PubMed
  49. An W et al. 2019. British journal of pharmacology. 176(5):699-710 . PubMed
  50. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  51. Lu X, et al. 2020. Sci Transl Med. 12:. PubMed
  52. Guérin MV, et al. 2019. Nat Commun. 10:4131. PubMed
  53. Liao T, et al. 2017. Front Immunol. 8:1334. PubMed
  54. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  55. Wang Y, et al. 2022. Cell Death Dis. 13:748. PubMed
  56. Golden TN, et al. 2022. Front Pharmacol. 12:761496. PubMed
  57. Cai C, et al. 2021. Sci Rep. 11:13386. PubMed
  58. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  59. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  60. Lee DH, et al. 2019. PLoS One. 14:e0215727. PubMed
  61. Yu Y, et al. 2018. Mol Med Rep. 17:8212. PubMed
  62. Miura I, et al. 2021. Physiol Rep. 9:e14859. PubMed
  63. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  64. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  65. Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed
  66. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  67. Shu Y, et al. 2020. Immunology. 160:345. PubMed
  68. Ying W, et al. 2016. Sci Rep. 6:20176. PubMed
  69. Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed
  70. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  71. Chu SY, et al. 2019. Nat Commun. 10:1524. PubMed
  72. Qiu N, et al. 2021. J Nanobiotechnology. 19:428. PubMed
  73. Yang C, et al. 2022. Nat Commun. 13:4866. PubMed
  74. Lu X, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2358. PubMed
  75. Bhattacharya A, et al. 2018. Neuropsychopharmacology. 43:2586. PubMed
  76. Anderson-Baucum E, et al. 2021. Cell Metab. 33:1883. PubMed
  77. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  78. Wang X, et al. 2022. J Biol Chem. 298:101561. PubMed
  79. Lowe PP, et al. 2020. J Neuroinflammation. 0.913888889. PubMed
  80. Zhou K, et al. 2016. J Cereb Blood Flow Metab. 10.1177/0271678X16648712. PubMed
  81. Deng W, et al. 2015. Clin Immunol. . PubMed
  82. Lu SW, et al. 2020. Nat Commun. 3.660416667. PubMed
  83. Budai Z, et al. 2021. Cells. 10:. PubMed
  84. Zhu Q, et al. 2022. Atherosclerosis. 357:41. PubMed
  85. Asterholm I, et al. 2012. J Lipid Res. 53: 1254. PubMed
  86. Stridh L, et al. 2013. J Neurosci. 33:12401. PubMed
  87. Long L, et al. 2018. Bio Protoc. 8:e2815. PubMed
  88. Li C, et al. 2019. JCI Insight. 5. PubMed
  89. Di Lorenzo A, et al. 2022. Oncoimmunology. 11:2086752. PubMed
  90. Li Y, et al. 2020. Theranostics. 10:2897. PubMed
  91. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  92. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  93. Suzuki T, et al. 2017. Cell Rep. 18(8):2045-2057. PubMed
  94. Krukowski K, et al. 2018. Sci Rep. 8:7857. PubMed
  95. Liu C, et al. 2022. Cell Death Discov. 8:269. PubMed
  96. Sears SM, et al. 2022. Kidney360. 3:818. PubMed
  97. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  98. Ukah T, et al. 2017. J Immunol. 10.4049/jimmunol.1700410. PubMed
  99. Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed
  100. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  101. Liu YS, et al. 2021. Cancers (Basel). 13:. PubMed
  102. Budhu S, et al. 2021. Cell Reports. 34(2):108620. PubMed
  103. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  104. Browne A, et al. 2015. Cancer Res . 75: 2811 - 2821. PubMed
  105. Moreno M et al. 2014. The Journal of Neuroscience. 34(24):8175-85 . PubMed
  106. Zhang J, et al. 2020. J Cell Mol Med. 24:4547. PubMed
  107. Al-Zaeed N, et al. 2021. Cell Death Dis. 12:611. PubMed
  108. Golabek A, et al. 2021. Exp Ther Med. 21:482. PubMed
  109. Yeini E, et al. 2021. Nat Commun. 12:1912. PubMed
  110. Xu GY, et al. 2022. Small. 18:e2107838. PubMed
  111. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  112. Li B et al. 2019. Cell reports. 26(10):2720-2737 . PubMed
  113. Morioka S, et al. 2018. Nature. 563:714. PubMed
  114. Mellal K, et al. 2019. Sci Rep. 9:12903. PubMed
  115. Yuan Y, et al. 2019. Clin Sci (Lond). 133:1759. PubMed
  116. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  117. Cai T, et al. 2022. Front Immunol. 13:1009932. PubMed
  118. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  119. Guo S, et al. 2021. Chronic Dis Transl Med. 7:254. PubMed
  120. Zheng H, et al. 2021. Frontiers in Immunology. 12:645100. PubMed
  121. Chuan Li et al. 2017. Endocrinology. 158(9):2837-2847 . PubMed
  122. Wen HJ, et al. 2019. Cell Mol Gastroenterol Hepatol. 8:p173. PubMed
  123. Yuan M, et al. 2017. Hum Reprod. 32:94. PubMed
  124. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  125. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
RRID
AB_10896421 (BioLegend Cat. No. 141705) AB_10895754 (BioLegend Cat. No. 141706)

Antigen Details

Structure
Type I transmembrane protein, 175 kD, C-type lectin superfamily
Distribution

Macrophages, dendritic cells, Langerhans cells, liver endothelial cells

Function
Pathogen recognition, endocytosis and phagocytosis, antigen presentation
Ligand/Receptor
Antigen containing mannose, fucose, or an N-acetyl glucosamine
Cell Type
Dendritic cells, Endothelial cells, Langerhans cells, Macrophages
Biology Area
Cell Biology, Immunology, Innate Immunity, Signal Transduction
Molecular Family
CD Molecules
Antigen References

1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501.
2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469.
3. Burgdorf S, et al. 2006. J. Immunol. 176:6770.
4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975.

Gene ID
17533 View all products for this Gene ID
UniProt
View information about CD206 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线